Research on Xeloda to treat TNBC:
New research suggesting Omeprozole (heartburn/acid reflux medicine) improves effectiveness of chemo for early TNBC:
in case anyone hasn’t seen Breast Cancer Now’s response on this TNBC mix for secondary:
Update on phenotyping for TNBC for anyone interested in cancer metabolism:
This is an interesting research paper regarding metabolic mapping for a Triple Negative and associated clinical trials:
A new targeted therapy for TNBC on the horizon (USA FDA approved so don’t know what NICE are doing about it for the NHS?)
Barts Hospital have a curent trial with immunotherapy for secondary TN, first line of treatment. They are having a good response I think. Might be worth looking into it. Prof Schmidt is leading it.
New article on targeted therapy for triple negative: